Cargando…

The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC

INTRODUCTION: Although multiple targeted treatments have appeared, hepatocellular carcinoma (HCC) is still one of the most common causes of cancer-related deaths. The immunosuppressive tumor microenvironment (TME) is a critical factor in the oncogenesis and progression of HCC. The emerging scRNA-seq...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yanying, Sun, Lu, Chen, Zhouyi, Liu, Weiren, Xu, Qiyue, Liu, Fangming, Ma, Mingyue, Chen, Yuwen, Lu, Yan, Fang, Hao, Chen, Geng, Shi, Yinghong, Wu, Duojiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948089/
https://www.ncbi.nlm.nih.gov/pubmed/36845133
http://dx.doi.org/10.3389/fimmu.2023.1033497
_version_ 1784892702124408832
author Yang, Yanying
Sun, Lu
Chen, Zhouyi
Liu, Weiren
Xu, Qiyue
Liu, Fangming
Ma, Mingyue
Chen, Yuwen
Lu, Yan
Fang, Hao
Chen, Geng
Shi, Yinghong
Wu, Duojiao
author_facet Yang, Yanying
Sun, Lu
Chen, Zhouyi
Liu, Weiren
Xu, Qiyue
Liu, Fangming
Ma, Mingyue
Chen, Yuwen
Lu, Yan
Fang, Hao
Chen, Geng
Shi, Yinghong
Wu, Duojiao
author_sort Yang, Yanying
collection PubMed
description INTRODUCTION: Although multiple targeted treatments have appeared, hepatocellular carcinoma (HCC) is still one of the most common causes of cancer-related deaths. The immunosuppressive tumor microenvironment (TME) is a critical factor in the oncogenesis and progression of HCC. The emerging scRNA-seq makes it possible to explore the TME at a high resolution. This study was designed to reveal the immune-metabolic crosstalk between immune cells in HCC and provide novel strategies to regulate immunosuppressive TME. METHOD: In this study, we performed scRNA-seq on paired tumor and peri-tumor tissues of HCC. The composition and differentiation trajectory of the immune populations in TME were portrayed. Cellphone DB was utilized to calculate interactions between the identified clusters. Besides, flow cytometry, RT-PCR and seahorse experiments were implemented to explore potential metabolic and epigenetic mechanisms of the inter-cellular interaction. RESULT: A total of 19 immune cell clusters were identified and 7 were found closely related to HCC prognosis. Besides, differentiation trajectories of T cells were also presented. Moreover, a new population, CD3+C1q+ tumor-associated macrophages (TAM) were identified and found significantly interacted with CD8+ CCL4+T cells. Compared to the peri-tumor tissue, their interaction was attenuated in tumor. Additionally, the dynamic presence of this newly found cluster was also verified in the peripheral blood of patients with sepsis. Furthermore, we found that CD3+C1q+TAM affected T cell immunity through C1q signaling-induced metabolic and epigenetic reprogramming, thereby potentially affecting tumor prognosis. CONCLUSION: Our study revealed the interaction between CD3+C1q+TAM and CD8+ CCL4+T cells and may provide implications for tackling the immunosuppressive TME in HCC.
format Online
Article
Text
id pubmed-9948089
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99480892023-02-24 The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC Yang, Yanying Sun, Lu Chen, Zhouyi Liu, Weiren Xu, Qiyue Liu, Fangming Ma, Mingyue Chen, Yuwen Lu, Yan Fang, Hao Chen, Geng Shi, Yinghong Wu, Duojiao Front Immunol Immunology INTRODUCTION: Although multiple targeted treatments have appeared, hepatocellular carcinoma (HCC) is still one of the most common causes of cancer-related deaths. The immunosuppressive tumor microenvironment (TME) is a critical factor in the oncogenesis and progression of HCC. The emerging scRNA-seq makes it possible to explore the TME at a high resolution. This study was designed to reveal the immune-metabolic crosstalk between immune cells in HCC and provide novel strategies to regulate immunosuppressive TME. METHOD: In this study, we performed scRNA-seq on paired tumor and peri-tumor tissues of HCC. The composition and differentiation trajectory of the immune populations in TME were portrayed. Cellphone DB was utilized to calculate interactions between the identified clusters. Besides, flow cytometry, RT-PCR and seahorse experiments were implemented to explore potential metabolic and epigenetic mechanisms of the inter-cellular interaction. RESULT: A total of 19 immune cell clusters were identified and 7 were found closely related to HCC prognosis. Besides, differentiation trajectories of T cells were also presented. Moreover, a new population, CD3+C1q+ tumor-associated macrophages (TAM) were identified and found significantly interacted with CD8+ CCL4+T cells. Compared to the peri-tumor tissue, their interaction was attenuated in tumor. Additionally, the dynamic presence of this newly found cluster was also verified in the peripheral blood of patients with sepsis. Furthermore, we found that CD3+C1q+TAM affected T cell immunity through C1q signaling-induced metabolic and epigenetic reprogramming, thereby potentially affecting tumor prognosis. CONCLUSION: Our study revealed the interaction between CD3+C1q+TAM and CD8+ CCL4+T cells and may provide implications for tackling the immunosuppressive TME in HCC. Frontiers Media S.A. 2023-02-09 /pmc/articles/PMC9948089/ /pubmed/36845133 http://dx.doi.org/10.3389/fimmu.2023.1033497 Text en Copyright © 2023 Yang, Sun, Chen, Liu, Xu, Liu, Ma, Chen, Lu, Fang, Chen, Shi and Wu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yang, Yanying
Sun, Lu
Chen, Zhouyi
Liu, Weiren
Xu, Qiyue
Liu, Fangming
Ma, Mingyue
Chen, Yuwen
Lu, Yan
Fang, Hao
Chen, Geng
Shi, Yinghong
Wu, Duojiao
The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC
title The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC
title_full The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC
title_fullStr The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC
title_full_unstemmed The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC
title_short The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC
title_sort immune-metabolic crosstalk between cd3(+)c1q(+)tam and cd8(+)t cells associated with relapse-free survival in hcc
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948089/
https://www.ncbi.nlm.nih.gov/pubmed/36845133
http://dx.doi.org/10.3389/fimmu.2023.1033497
work_keys_str_mv AT yangyanying theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT sunlu theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT chenzhouyi theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT liuweiren theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT xuqiyue theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT liufangming theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT mamingyue theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT chenyuwen theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT luyan theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT fanghao theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT chengeng theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT shiyinghong theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT wuduojiao theimmunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT yangyanying immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT sunlu immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT chenzhouyi immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT liuweiren immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT xuqiyue immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT liufangming immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT mamingyue immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT chenyuwen immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT luyan immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT fanghao immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT chengeng immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT shiyinghong immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc
AT wuduojiao immunemetaboliccrosstalkbetweencd3c1qtamandcd8tcellsassociatedwithrelapsefreesurvivalinhcc